Vodafone Technology Is Bringing Clinical Trial Results In Real-Time

Vodafone and PHT Corporation, are working together to connect the PHT electronic clinical outcome assessment (eCOA) system to Vodafone’s global M2M network. Vodafone’s Machine-to-Machine (M2M) Technology Enables PHT Corporation to more efficiently manage worldwide clinical trials through real-time access to patient experience data. Learn more here. (Source: Vodafone, 3/24/15)

You might also be interested in:

What Does $11M in Donations to Congress Buy Pharma? 08/12/2020
New JCP Series Looks at Progress of Clinical Pathways 06/17/2020
Key Innovations Coming From The Next Generation of PBM’s 08/12/2020
Stanford Center for Health Education Launches Online Program… 08/11/2020
Addressing the Affordability Crisis of Cell & Gene Therapies 12/16/2020
Data Exchange for Drug Rebate Processing and Contract… 08/31/2020
Robert Dubois, MD, PhD, Steps in as Interim President and CEO… 09/01/2020